ERK1/2在LPS诱导微血管内皮细胞细胞因子产生和通透性中具有不同作用
该研究在原代人肺微血管内皮细胞(HMVEC)和原代人单核细胞中探讨ERK1/2在LPS诱导炎症激活和通透性中的作用。ERK1/2抑制或siRNA敲低增强LPS诱导的HMVEC产生IL-6,ERK1/2抑制还增强VCAM-1产生;相反,ERK1/2抑制消除LPS处理的HMVEC通透性并恢复细胞间连接。在单核细胞中,ERK1/2抑制减少LPS诱导的细胞因子/趋化因子产生。ERK1/2在内皮细胞TLR4激活中的作用不依赖MyD88和TRIF信号通路。作者认为ERK1/2可能在对脓毒症和损伤中内皮炎症和血管通透性的精细调节中起重要作用。
要点
- 在原代人肺微血管内皮细胞中,ERK1/2抑制增强LPS诱导的IL-6和VCAM-1产生。
- ERK1/2 siRNA敲低同样增强LPS处理的HMVEC产生IL-6。
- ERK1/2抑制消除LPS处理的HMVEC通透性并恢复细胞间连接。
- 在原代人单核细胞中,ERK1/2抑制减少LPS诱导的细胞因子/趋化因子产生。
- ERK1/2在HMVEC的TLR4激活中作用不依赖MyD88和TRIF信号通路。
适用人群与场景
- 原代人肺微血管内皮细胞(HMVEC)
- 原代人单核细胞
研究设计与关键结果
- 体外研究:在人肺微血管内皮细胞中,ERK1/2抑制增强LPS诱导的IL-6和VCAM-1产生,ERK1/2 siRNA敲低也增强IL-6产生。
- 体外研究:ERK1/2抑制消除LPS处理的HMVEC通透性并恢复细胞间连接。
- 体外研究:在原代人单核细胞中,ERK1/2抑制减少LPS诱导的细胞因子/趋化因子产生。
- 机制研究:ERK1/2在HMVEC的TLR4激活中作用不依赖MyD88和TRIF信号通路。
证据类型、等级与局限
- 证据类型:体外细胞实验(原代人肺微血管内皮细胞和原代人单核细胞)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为ERK1/2可能在对脓毒症和损伤中内皮炎症和血管通透性的精细调节中起重要作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Endothelial cells play a major role in inflammatory responses to infection and sterile injury. Endothelial cells express Toll-like receptor 4 (TLR4) and are activated by LPS to express inflammatory cytokines/chemokines, and to undergo functional changes, including increased permeability. The extracellular signal-regulated kinase 1/2 (ERK1/2) mediates pro-inflammatory signaling in monocytes and macrophages, but the role of ERK1/2 in LPS-induced activation of microvascular endothelial cells has not been defined. We therefore studied the role of ERK1/2 in LPS-induced inflammatory activation and permeability of primary human lung microvascular endothelial cells (HMVEC). Inhibition of ERK1/2 augmented LPS-induced IL-6 and vascular cell adhesion protein (VCAM-1) production by HMVEC. ERK1/2 siRNA knockdown also augmented IL-6 production by LPS-treated HMVEC. Conversely, ERK1/2 inhibition abrogated permeability and restored cell-cell junctions of LPS-treated HMVEC. Consistent with the previously described pro-inflammatory role for ERK1/2 in leukocytes, inhibition of ERK1/2 reduced LPS-induced cytokine/chemokine production by primary human monocytes. Our study identifies a complex role for ERK1/2 in TLR4-activation of HMVEC, independent of myeloid differentiation primary response gene (MyD88) and TIR domain-containing adaptor inducing IFN-β (TRIF) signaling pathways. The activation of ERK1/2 limits LPS-induced IL-6 production by HMVEC, while at the same time promoting HMVEC permeability. Conversely, ERK1/2 activation promotes IL-6 production by human monocytes. Our results suggest that ERK1/2 may play an important role in the nuanced regulation of endothelial cell inflammation and vascular permeability in sepsis and injury.
参考来源
- Wong E, Xu F, Joffre J, et al. ERK1/2 Has Divergent Roles in LPS-Induced Microvascular Endothelial Cell Cytokine Production and Permeability. Shock. 2021. PMID: 32826812. doi:10.1097/SHK.0000000000001639
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。